Polyphron Raises $20M for AI Tissue Sim

Polyphron, a New York company, raises $20M in seed funding led by Quiet Capital. The firm uses AI to simulate living human tissue, currently producing cardiac samples from over 20 donors to predict drug toxicity before clinical trials. Co-founders include Matthew Osman and Fabio Boniolo.